OR WAIT null SECS
October 08, 2020
Under the contract, Pharm-Olam will offer routine and response clinical services for the development of medical countermeasures.
FDA approved the first commercial drug manufactured via Aji Bio-Pharma's proprietary production process.
October 07, 2020
Schott and Credence MedSystems have formed a strategic collaboration to make syringe injections safer.
Enterprise Therapeutics has announced that its novel TMEM16A potentiator portfolio has been fully acquired by Roche
Independent research performed at the University of St. Andrews in the UK has reportedly demonstrated the effectiveness of Alfacyte in-vitro against SARS-CoV-2.
Following a recent expansion at its Cambridge, MA, facility, the company now houses a new suite of cellular analysis platforms that enhance its exploratory capabilities into oncology, neuroscience, and rare diseases.
The new personal capillary electrophoresis system, Spectrum Compact CE, performs Sanger sequencing and fragment analysis.
The company’s new CytoML Experiment Suite fully automates each stage of the flow cytometry data lifecycle, allowing for clearer data visualization and analysis.
October 06, 2020
Eudratec Fasteric is an oral drug delivery technology that offers enteric protection after rapid, homogeneous release for targeting the upper small intestine.
October 01, 2020
Sterling Pharma Solutions has acquired Alcami’s API facility in Germantown, WI.